Contains natural products and fractional extracts for cancer regulation. NPCARE offers 6578 natural compounds and 2566 fractional extracts isolated from 1952 distinct biological species including plants, marine organisms, fungi, and bacteria whose anticancer activities were validated with 1107 cell lines for 34 cancer types. It can serve as a dominant gateway for the discovery of new anticancer medicines due to the inclusion of a large number of the fractional extracts as well as the natural compounds isolated from a variety of biological resources.
Department of Bioscience and Biotechnology, Institute of Anticancer Medicine Development, Sejong University, Kwangjin gu, Seoul, Korea; College of Korean Medicine, Dongguk University, Ilsandong gu, Goyang si, Gyeonggi do, Korea; Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Sucho gu, Seoul, Korea; Department of Biological Sciences, KAIST, Yuseong gu, Daejeon, Korea; Graduate School of Medical Science and Engineering, KAIST, Yuseong gu, Daejeon, Korea; Department of Korean Gynecology, Jaseng Hospital of Korean Medicine, Gangnam gu, Seoul, Korea; College of Korean Medicine, Wonkwang University, Iksan, Jeonbuk, Korea; WiFun Team, Nexon, Bundang gu, Seongnam si, Gyeonggi do, Korea; Hanvit Dental-Medical Hospital, Wonju, Gangwon do, Korea; Department of Clinical Korean Medicine, Kyung Hee University Korean Medicine Hospital, Dongdaemun gu, Seoul, Korea
NPCARE funding source(s)
Supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2016R1D1A1B01014187).